RBC
GILD icon

Roble Belko & Company’s Gilead Sciences GILD Stock Holding History

Roble Belko & Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28K Hold
218
– – ﹤0.01% 250
2026
Q1 		$30K Hold
218
– – ﹤0.01% 240
2025
Q4 		$27K Hold
218
– – ﹤0.01% 248
2025
Q3 		$24K Hold
218
– – ﹤0.01% 223
2025
Q2 		$24K Hold
218
– – ﹤0.01% 225
2025
Q1 		$24K Hold
218
– – ﹤0.01% 211
2024
Q4 		$20K Hold
218
– – ﹤0.01% 216
2024
Q3 		$18K Hold
218
– – ﹤0.01% 209
2024
Q2 		$15K Hold
218
– – ﹤0.01% 223
2024
Q1 		$16K Hold
218
– – ﹤0.01% 228
2023
Q4 		$18K Hold
218
– – ﹤0.01% 209
2023
Q3 		$16K Hold
218
– – ﹤0.01% 192
2023
Q2 		$17K Hold
218
– – ﹤0.01% 193
2023
Q1 		$18K Hold
218
– – ﹤0.01% 203
2022
Q4 		$19K Buy
+218
New +$17.3K ﹤0.01% 216
2017
Q3 		– Sell
-235
Closed -$17K – 296
2017
Q2 		$17K Sell
235
-82
-26% -$5.46K 0.01% 149
2017
Q1 		$22K Sell
317
-625
-66% -$43.9K 0.01% 136
2016
Q4 		$67K Sell
942
-663
-41% -$49.3K 0.04% 87
2016
Q3 		$127K Buy
1,605
+266
+20% +$21.6K 0.07% 63
2016
Q2 		$112K Buy
1,339
+1,035
+340% +$91.9K 0.06% 70
2016
Q1 		$28K Buy
304
+204
+204% +$18.4K 0.02% 117
2015
Q4 		$10K Hold
100
– – 0.01% 146
2015
Q3 		$10K Hold
100
– – 0.01% 139
2015
Q2 		$12K Buy
+100
New +$10.9K 0.01% 149

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Roble Belko & Company's GILD Position: Q2 2026 in Review

Roble Belko & Company held its Gilead Sciences (GILD) position steady in Q2 2026 at 218 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #250.

Roble Belko & Company first reported a position in GILD in Q2 2015 and has held it in 24 quarters since. The position peaked at $127K in Q3 2016. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Roble Belko & Company held 218 shares of Gilead Sciences worth $28K as of Q2 2026.
  • Roble Belko & Company left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Roble Belko & Company's portfolio in Q2 2026, its #250 holding.
  • Roble Belko & Company first reported a position in Gilead Sciences in Q2 2015 and has held it in 24 quarters since.
  • Roble Belko & Company's Gilead Sciences position peaked at $127K in Q3 2016.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.